Testing effectiveness (Phase 2)Study completedNCT01612351
What this trial is testing
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of the Head and Neck
UNC Lineberger Comprehensive Cancer Center 40